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Abstract
Background: Bacteria that produce Klebsiella pneumoniae carbapenemases (KPCs) are resistant to broad-spectrum
β-lactam antibiotics. The objective of this study was to phenotypically and genotypically characterize the antibiotic
susceptibility to carbapenems of 297 isolates recovered from clinical samples obtained from inpatients at 16
hospitals in São Luis (Maranhão, Brazil).
Methods: The study was conducted using phenotypic tests and molecular methods, including polymerase chain
reaction (PCR), sequencing and enterobacterial repetitive intergenic consensus (ERIC)-PCR. The nonparametric
chi-square test of independence was used to evaluate the associations between the bacterial blaKPC gene and
the modified Hodge test, and the chi-square adherence test was used to assess the frequency of carbapenemases and
their association with the blaKPC gene.
Results: The most frequently isolated species were Acinetobacter baumannii (n = 128; 43.0%), K. pneumoniae (n = 75; 25.
2%), and Pseudomonas aeruginosa (n = 42; 14.1%). Susceptibility assays showed that polymixin B was active against 89.
3% of the bacterial isolates. The Acinetobacter spp. and K. pneumoniae strains were susceptible to amikacin
and tigecycline, and Pseudomonas spp. were sensitive to gentamicin and amikacin. Among the 297 isolates, 100 (33.
7%) were positive for the blaKPC gene, including non-fermentative bacteria (A. baumannii) and Enterobacteriaceae
species. Among the isolates positive for the blaKPC gene, K. pneumoniae isolates had the highest positivity rate of 60.0%.
The blaKPC gene variants detected included KPC-2, which was found in all isolates belonging to species of the
Enterobacteriaceae family. KPC-2 and KPC-3 were observed in A. baumannii isolates. Importantly, the blaKPC gene was
also detected in three Raoultella isolates and one isolate of the Pantoea genus. ERIC-PCR patterns showed a high level
of genetic diversity among the bacterial isolates; it was capable of distinguishing 34 clones among 100 strains that
were positive for blaKPC and were circulating in 11 of the surveyed hospitals.
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Conclusions: The high frequency of the blaKPC gene and the high degree of clonal diversity among microorganisms
isolated from patients from different hospitals in São Luis suggest the need to improve the quality of health care to
reduce the incidence of infections and the emergence of carbapenem resistance in these bacteria as well as other
Gram-negative pathogens.
Keywords: Klebsiella pneumoniae carbapenemases (KPCs), blaKPC gene variants, Multidrug-resistance (MDR),
Enterobacterial repetitive intergenic consensus PCR (ERIC-PCR)
Background
Klebsiella pneumoniae carbapenemases (KPCs) are β-
lactamases commonly produced by blaKPC gene-
harboring bacteria of the Enterobacteriaceae family,
such as Klebsiella pneumoniae, Escherichia coli and
Enterobacter spp. [1, 2]. These enzymes hydrolyze a
wide spectrum of β-lactams, including penicillins,
cephalosporins, and carbapenems [3]. The blaKPC
gene possesses different variants (KPC-2 to KPC-15)
that are sporadically found in other species, such as
non-fermenting bacteria [4–7].
The dispersion of bacteria carrying the blaKPC gene in
hospitals is a growing concern due to increased resist-
ance to carbapenems, such as imipenem and merope-
nem, with significant increases observed in the
minimum inhibitory concentrations (MICs) of these
drugs for K. pneumoniae and other pathogens [8].
Furthermore, this dispersion appears to have in-
creased globally, mainly in South America, with re-
cent reports in Argentina and Brazil following the
first report in Colombia in 2006 [9–11]. There is jus-
tifiable concern that new variants may arise, and hori-
zontal transfer of the blaKPC gene has been detected
in other bacterial species commonly found in the hos-
pital environment [12].
Most bacteria carrying the blaKPC gene usually harbor
other resistance genes, leading to resistance to multiple
classes of antimicrobials, such as aminoglycosides and
fluoroquinolones [13, 14]. When a carrier of a KPC vari-
ant gene evolves into a multidrug-resistant (MDR)
microorganism, standard medical treatment has been
found to be ineffective, and such infections are accom-
panied by high mortality rates [15].
In this study, we detected KPCs by phenotypic tests,
such as the modified Hodge test (MHT), to confirm the
presence of carbapenemase activity as recommended by
the Clinical and Laboratory Standards Institute (CLSI),
and the E-Test® (gradient method). Polymerase chain
reaction (PCR) and genomic sequencing were used
for the detection and identification of blaKPC gene
variants. Additionally, enterobacterial repetitive inter-
genic consensus (ERIC)-PCR was used to determine




Clinical samples, including fluid abscess, rectal swab,
blood, catheter tip, drenage secretion, nasal swab, surgi-
cal wound, tracheal secretion, and urine, were collected
from June 2012 to July 2013, from inpatients at different
hospitals that provide general assistance, emergency and
outpatient care in São Luis city, Maranhão, Brazil. Of
the 16 hospitals that provided samples, 14 (H01 to H10
and H13 to H16) were public hospitals in the São Luis
public health system, and two (H11 and H12) were pri-
vate healthcare facilities (Table 1). Biological samples
were sent to the Laboratory Cedro (provider of services
of Clinical Microbiology to all municipal and state hos-
pitals fom the state of Maranhao). The following epi-
demiological data were provided by the hospitals:
anatomical site of origin, hospital accomodation, and
distribution by hospital sector.
Isolation and identification of bacterial strains
Biological specimens were processed in the Clinical
Microbiology Section from Laboratory Cedro, where
bacterial strains were isolated using MacConkey agar
(Difco, Detroit, MI, USA), blood agar (bioMérieux),
brain heart infusion (BHI) broth (Difco, Detroit, MI,
USA) and CPS chromogenic agar (bioMérieux). Subse-
quently, the isolates were identified with Gram-negative
(GN) cards, and their susceptibility profiles were deter-
mined using antimicrobial susceptibility (AST) test cards
(N209 cards) by using the Vitek® 2 Compact system (bio-
Mérieux, Marcy l’Etoile, France), according to the manu-
facturer’s instructions.
Of the isolates evaluated, 654 showed low sensitivity to
carbapenems imipenem, meropenem or ertapenem and
were frozen at −80 °C in BHI with 20% glycerol. We ran-
domly selected 297 (45.4%) strains for this study. To en-
sure that there were no repeated bacterial isolates from
the same patient, each selected bacterial strain had a
code related to a patient’s medical record. At the Mo-
lecular Biology Laboratory of Microorganisms from Uni-
versity Ceuma, the bacterial strains were checked for
purity. Confirmation of biochemical identification of all
bacterial isolates was carried out by conventional tests.
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Disk diffusion antibiotic sensitivity testing
To confirm the antimicrobial susceptibility pattern of
each clinical isolate, we performed the disk-diffusion
(Kirby-Bauer) test on Mueller-Hinton agar with the fol-
lowing antimicrobial discs (Oxoid® Limited, Basingstoke,
UK): AMI, amikacin (30 μg); AMP, ampicillin (10 μg);
ASB, ampicillin/sulbactam (10/10 μg); ATM, aztreonam
(30 μg); CFL, cephalothin (30 μg); CEF, cefepime (30 μg),
CTX, cefotaxime (30 μg); CFO, cefoxitin (30 μg); CAZ,
ceftazidime (30 μg), CIP, ciprofloxacin (5 μg); ERT, erta-
penem (10 μg); GEN, gentamicin (10 μg); IMP, imipe-
nem (10 μg); MER, meropenem (10 μg); and PTZ,
piperacillin/tazobactam (100/10 μg); POL, Polymixin B
(300 U); TIG, Tigecicline (15 μg). The diameters of
zones of inhibition were measured, and results were
interpreted in accordance with the criteria of Clinical
and Laboratory Standards Institute [16].
Determination of minimum inhibitory concentrations of
carbapenems by E-Test®
The MICs were determined by the E-Test® (AB Biodisk,
Solna, Sweden), according to the manufacturer’s instruc-
tions. The microorganism classifications included sensi-
tive, intermediate and resistant to the antimicrobials,
using breakpoints recommended by the document
M100-S23 of the Clinical and Laboratory Standards
Institute methods [16].
Modified Hodge testing
The confirmation of carbapenemase activity was per-
formed using a MHT as previously described [16]. The
K. pneumoniae strain ATCC BAA-1706® was used as a
negative control and K. pneumoniae ATCC BAA-1705®
was used as a positive control. The presence of a distorted
or clover leaf-shaped inhibition zone was interpreted as
positive for carbapenemase-producing isolates, as recom-
mended by the document M100-S24 of the Clinical and
Laboratory Standards Institute methods [16].
Molecular identification of isolated bacterial strains
resistant to carbapenem
Total genomic DNA from the clinical isolates was ob-
tained using a Wizard® Genomic DNA Purification Kit
(Promega Corporation, Madison, USA), according to the
manufacturer’s instructions. The concentration and pur-
ity of the extracted DNA were verified using a
Nanodrop-ND1000 (Thermo Fisher Scientific, Waltham,
MA, USA).
PCR assays were performed with primers for the blaKPC
family, Uni-KPC-F (5’-ATGTCACTGTATCGCCGTCT-3’)
and Uni-KPC-R (5’-TTACTGCCCGTTGACGCCC-3’), as
previously described [17]. This pair of primers amplifies the
complete sequence of the blaKPC gene (882 nucleotides).
The PCR was performed in a Mastercycler thermocycler
(Eppendorf, Foster City, California, USA) with AccuPrime
DNA polymerase mix (1X buffer BII; 2 mM each dNTPs;
1.5 mM MgCl2; 200 mM Tris–HCl pH 8.4 and 1.5 U
AccuPrime Taq DNA polymerase) (Invitrogen/Stratagene,
La Jolla, CA, USA), 20 pmol of each primer, and 50 ng of
genomic DNA to a final volume of 50 μl. The amplification
reaction was performed using the following condi-
tions: 94 °C for 3 min (initial denaturation) followed
by 30 cycles of 94 °C for 1 min, 55 °C for 1 min and 72 °C
for 1 min, and a final extension step at 72 °C for 5 min.
To verify the efficiency of the PCR and determine the
sizes of the amplified DNA fragments, 8 μl of each PCR
product was analyzed by electrophoresis on a 1.2% (wt/
vol) agarose gel in Tris-acetate-EDTA buffer (TAE:
40 mM Tris-acetate and 1 mM EDTA). A 100 bp DNA
ladder (Promega Corporation, Madison, USA) was in-
cluded in each run. After electrophoresis, the agarose
gels were stained with ethidium bromide (0.5 μg/ml) and
photographed under ultraviolet light (UV) at 260 nm.
Purification and sequencing of PCR products
To determine which blaKPC variants were circulating in
patients from hospitals in São Luis, Maranhão, the 882-bp
amplified PCR products were purified using a commercial
Wizard® SV Gel and PCR Clean-Up System Kit (both from
Promega Corporation, Madison, USA), according to the
manufacturer’s instructions. PCR purified products were
sequenced by Myleus Biotechnology (Belo Horizonte,
Minas Gerais, Brazil) using an ABI 3730XL DNA analyzer
(Applied Biosystems, Carlsbad, CA, USA). Amplicons
were bidirectionally sequenced at least three times; thus,
each PCR product was sequenced six times.
The quality of the sequence electropherograms ob-
tained during the sequencing process was analyzed
with ChromasPro (http://www.technelysium.com.au/
chromas.html) software. At least two sequences of
each type of KPC were chosen from the database for
alignments using MEGA 4.0 [18]. Similarities between
the nucleotide sequences obtained were verified using
BLASTN (https://blast.ncbi.nlm.nih.gov/Blast.cgi).
To identify the blaKPC gene variants, all sequences
were translated into amino acids using the software
ExPASy [translate tool (http://web.expasy.org/translate/)
in the six reading frames]. The correct translation was
chosen based on the available data in GenBank. Deduced
amino acid sequences were compared with KPC protein
sequences from GenBank using BLASTX. Similarity
values for amino acid sequences ranged from 99 to
100%, indicating a highly conserved region.
Identification of Acinetobacter baumannii by detection of
the blaOXA-51-like carbapenemase gene
PCR assays for blaOXA-51-like carbapenemase, a gene in-
trinsic to this species, were performed for all isolates
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identified by biochemical tests as Acinetobacter. As a
positive control, we used a strain of A. baumannii
ATCC19606. Amplifications were carried out with specific
primers previously described [19], and the PCR products
were analysed by electrophoresis on a 2.0% (wt/vol) agar-
ose gel containing 0.5 μg/ml ethidium bromide.
ERIC-PCR amplifications and profile analysis
ERIC-PCR amplifications were used for molecular typing of
all isolates analyzed in this study. PCR assays were per-
formed with 100 ng of genomic bacterial DNA, 10 pmol of
each ERIC-1R (5’-ATGTAAGCTCCTGGGGATTCAC-3’)
and ERIC-2 (5’-AAGTAAGTGACTGGGGTGAGCG-3’)
primer (Invitrogen, Carlsbad, CA, USA), as previously de-
scribed [20], plus 12.5 μl of Master Mix (Promega Corpor-
ation, Madison, USA) and ultra-pure water to bring the
final reaction volume to 25 μl. The PCR conditions in-
cluded an initial denaturation at 94 °C for 3 min followed
by 35 cycles of 94 °C for 30 s, 52 °C for 1 min, and 72 °C
for 2 min, with a final extension at 72 °C for 6 min. PCR
amplicons were resolved by electrophoresis on a 2% (w/v)
agarose gel in acetate-EDTA buffer. A 100 bp DNA ladder
(Promega Corporation, Madison, USA) was included in
each run. After electrophoresis, the gels were stained with
ethidium bromide (0.5 μg/ml), and photographed under
UV at 260 nm.
ERIC-PCR profiles were scored by fragment size with
the LabImage-1D gel analysis software, Version 3.2 (1D:
V6.2. Available in: http://www.kapelanbio.com/). Ampli-
fied fragments were scored as absent (0) or present (1)
to construct a dendrogram. ERIC-PCR genotype dendro-
grams were constructed based on the average similarity
of the matrix using the unweighted pair group method
with arithmetic mean and the DICE similarity coefficient
using NTSYS-pc version 2.1, Exeter Software (New
York, NY, USA). The nearest neighbor-joining clustering
method was used to show relationships between similar
groups.
Statistical analysis
To evaluate the associations between the blaKPC gene
variants and the modified Hodge test, the nonparametric
chi-square test of independence was used. To assess the
frequency of carbapenemases and their association with
the presence of the blaKPC gene, we used the chi-square
adherence test. The data were considered statistically
significant at p < 0.05.
Results
Identification of bacterial species and susceptibility tests
In the present study, susceptibility testing was performed
on 297 bacterial strains (Enterobacteriaceae and non-
fermentative Gram-negative bacilli) isolated from June
2012 to July 2013, which showed decreased sensitivity to
imipenem, ertapenem or meropenem. These bacterial
strains belonged to the genera Acinetobacter, Klebsiella,
Enterobacter, Pseudomonas, Serratia, Pantoea, Proteus,
Escherichia, Raoultella, and Aeromonas. Most of the
strains were identified as A. baumannii (n = 128, 43.1%),
K. pneumoniae (n = 75, 25.2%), and P. aeruginosa (n =
42, 14.1%).
The susceptibility testing and minimum inhibitory
concentrations of bacterial species indicated that mem-
bers of the Enterobacteriaceae family had elevated MICs
for most antimicrobial agents tested, except for Poly-
mixin. For meropenem and imipenem, a MIC of ≥
32 μg/ml was detected for all strains of K. pneumoniae.
Simultaneous drug resistance to fluoroquinolones, ami-
noglycosides and other β-lactam antibiotics was ob-
served for 66 bacterial isolates (Table 2). In addition, low
percentages of resistance to amikacin were observed for
most strains. K. pneumoniae isolates were susceptible to
amikacin and tigecycline; Raoultella planticola isolates
showed sensitivity only to amikacin; and R. ornithinoly-
tica showed sensitivity to amikacin, gentamicin, and
tigecycline. S. marcescens strains, which are intrinsically
resistant to Polymixin B, were highly sensitive to fluoro-
quinolone (ciprofloxacin) (Table 2).
The multidrug-resistant (MDR) non-fermentative
isolates were susceptible to Polymixin B, with an MIC
of ≤ 0.5 μg/ml for all isolates. A. baumannii and
P. aeruginosa had MICs of ≥16 μg/ml for meropenem
and imipenem. In addition, MICs of ≥ 64 μg/ml for
amikacin and 4 μg/ml for tigecycline were found in
Acinetobacter spp. isolates, and MICs of ≥ 64 μg/ml
for amikacin and ≥ 16 μg/ml for gentamicin were
found in Pseudomonas spp. isolates; the antimicrobial
resistance profiles of the other isolates showed values
above 50% (Table 3).
Evaluation of the modified Hodge test (MHT)
The results of the MHT indicated a statistically signifi-
cant association (p = 0.0001) with the assessed bacterial
species. We observed that the microorganism with the
highest positive test results was K. pneumoniae [60
(80%) of 75 isolates], followed by Enterobacter cloacae [7
(36.8%)]. (Table 4). There is no standardization of this
test for non-fermenting bacteria (Acinetobacter spp. and
Pseudomonas spp.) in the document M100-S24 of the
Clinical and Laboratory Standards Institute methods
[16]. Thus, for these microorganisms, the MHT was not
performed.
Detection of the blaKPC gene in bacterial isolates with
decreased susceptibilities to carbapenems
We found a statistically significant correlation between
the blaKPC gene and bacterial species by the nonpara-
metric chi-square test of independence (p < 0.05). The
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blaKPC gene was detected in 100 (33.7%) of the 297 iso-
lates evaluated in this study, including fermenting (Entero-
bacteriaceae) and non-fermenting (Pseudomonas and
Acinetobacter) species. The blaKPC gene was detected in
K. pneumoniae (60 strains; 80.0%), E. aerogenes (6 strains;
66.7%), E. coli (1 strain; 50%), Serratia marcescens (2
strains; 40%), E. cloacae (6 strains; 31.6%), Raoultella plan-
ticola (2 strains; 100%), R. ornithinolytica (1 strain; 100%),
and Pantoea sp. (1 strain; 33.3%) (Table 4). Of the 128 iso-
lates of A. baumannii, 21 (16.4%) were positive for the
blaKPC gene.
The blaKPC gene was not detected in the following
bacterial species: Acinetobacter ursingii, Aeromonas sal-
monicida, Proteus mirabilis, P. aeruginosa, P. fluorescens
and P. putida, although these microorganisms showed
resistance or decreased susceptibility to carbapenems
Table 3 Antibiotic resistance profiles and minimal inhibitory concentrations for non-fermentative bacilli species
non-fermentative gram-negative bacilli
Antibiotics Acinetobacter baumannii Acinetobacter ursingii Pseudomonas aeruginosa Pseudomonas fluorescens Pseudomonas putida
% MIC % MIC % MIC % MIC % MIC
amikacin 22.7 ≥64 0.0 4 28.6 ≥64 0.0 ≤2 0.0 16
ampicillin 100 ≥32 100 ≥32 100 ≥32 100 ≥32 100 ≥32
amp/sulbaca 72.7 ≥32 100 ≥32 100 ≥32 100 ≥32 100 ≥32
aztreonam 100 ≥64 100 ≥64 NTc NTc NTc NTc NTc NTc
cephalothin 100 ≥64 100 ≥64 NTc NTc 100 ≥64 100 ≥64
cefepime 97.7 ≥64 100 ≥64 64.3 ≥64 100 ≥64 60.0 ≥64
cefotaxime 100 ≥64 100 ≥64 100 ≥64 NTc NTc 100 ≥64
cefoxitin 100 ≥64 100 ≥64 100 ≥64 100 ≥64 100 ≥64
ceftazidime 99.2 ≥64 100 ≥64 71.4 ≥64 100 ≥64 80.0 ≥64
ciprofloxacin 96.9 ≥4 0.0 ≤0.5 69.0 ≥4 100 ≥4 40.0 ≥4
polymyxin B 0.0 ≤0.5 0.0 ≤0.5 0.0 ≤0.5 0.0 ≤0.5 0.0 ≤0.5
gentamicin 53.1 ≥16 100 ≥16 59.5 ≥16 0.0 ≤1 20.0 ≥16
imipenem 100 ≥16 100 ≥16 100 ≥16 100 ≥16 100 ≥16
meropenem 100 ≥16 100 ≥16 100 ≥16 100 ≥16 100 ≥16
ertapenem NTc NTc NTc NTc NTc NTc NTc NTc NTc NTc
piper/tazobb 100 ≥128 100 ≥128 78.6 ≥128 0.0 16 60.0 ≥128
tigecycline 0.8 4 NTc NTc 100 ≥8 100 ≥8 100 ≥8




Table 4 Association of the blaKPC gene and the modified Hodge test with Enterobacteriaceae species
Enterobacteria Total blaKPC MHT
a blaKPC +MHT P
No. (%) No. (%) No. (%)
Enterobacter aerogenes 9 6 (66.7) 7 (77.8) 5 (55.6) 0.0001
Enterobacter cloacae 19 6 (31.6) 7 (36.8) 4 (21.1)
Escherichia coli 2 1 (50.0) 0 (0) 0
Klebsiella pneumoniae 75 60 (80.0) 60 (80.0) 49 (65.3)
Pantoea sp. 3 1 (33.3) 1 (33.3) 1 (33.3)
Proteus mirabilis 3 0 (0) 1 (33.3) 0 (0)
Raoultella planticola 2 2 (100) 2 (100) 2 (100)
Raoultella ornithinolytica 1 1 (100) 1 (100) 1 (100)
Serratia marcescens 5 2 (40.0) 3 (60.0) 2 (40.0)
Total 119 79 (66.4) 82 (68.9) 64 (53.7)
aMHT, modified Hodge test; P < 0.0001, Nonparametric chi-square test of independence
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(imipenem, meropenem or ertapenem) in phenotypic
tests.
We verified the high rate of blaKPC-positive K. pneu-
moniae among the isolates from four public hospitals:
H05, 100.0% (6/6); H08, 100.0% (1/1); H09, 100.0% (5/5);
H10, 80.0% (20/25) and H01, 75.0% (18/24). In addition,
a high frequency of this gene was detected in H12,
(71.4%, 10/14), a private hospital of high complexity in
São Luis, MA.
Regarding the association between the modified Hodge
test and the presence of the blaKPC gene in species of
the family Enterobacteriaceae, we observed positive re-
sults in both tests for 64 isolates (Table 4). Of import-
ance, the concordance rate between the two tests was of
81% (64 out of 79 that were positive for the blaKPC gene.
Of the non-glucose fermenting bacteria, only A. bau-
mannii isolates carried the blaKPC gene, and the largest
number of isolates was recovered from three public hos-
pitals in São Luis, MA: H02, 50.0% (5/10); H01, 19.0%
(7/37) and H10, 18.1% (8/44).
The phenotypic profiles obtained by different methods
(Vitek® 2, E-Test®, and the modified Hodge test) for all
isolates that showed resistance to carbapenem antibiotics
are shown in Table 5. Importantly, a high percentage of
antimicrobial-resistant microorganisms harbored the
blaKPC gene.
Statistical analyses using chi-square adherence tests re-
vealed that the presence of the blaKPC gene was signifi-
cantly correlated with the distribution of the isolates at
the site of infection (p < 0.0001). The highest frequency
of this gene in the clinical isolates was 46.9% (30/64) in
isolates from urine, followed by 39.5% (17/43) from
blood, 39.4% (13/33) in nasal swabs, 33.3% (5/15) in rec-
tal swabs and 21.4% in tracheal secretions (24/112).
Specimens obtained from other anatomical sites showed
low detection frequencies, which were probably due to
the lack of quantitative uniformity among the materials
collected during the study. Additionally, chi-square ad-
herence tests indicated a correlation between the fre-
quency of hospital accommodation and the presence of
the blaKPC gene (p < 0.0001).
The distribution of KPC-positive microorganisms by
hospital sector revealed that 56 (32.7%) isolates were
positive for the blaKPC gene in 171 samples derived from
the intensive care units (ICUs). By contrast, KPC-
producing bacteria were found in several other units, ex-
cept the pediatric ICU and the ward and labor rooms.
The blaKPC gene was also detected in bacterial isolates
from patients admitted to sectors, such as the intermedi-
ate care unit, with four (20.0%) of the 20 cases from H10
and three (60.0%) of the five cases from H05, a hospital
emergency room.
Sequencing of the blaKPC gene and amino acid sequence
analysis
The blaKPC gene was detected in 100 (33.7%) resistant
bacterial isolates, and similarities among the sequences
were assessed by performing alignments with nucleotide
sequences from different bacteria. All sequences were
deposited in GenBank with accession numbers
KU695917 to KU696016. The similarity indices ranged
from 99 to 100%, indicating that the sequenced region
was highly conserved.
Nucleotide and amino acid differences between KPC
enzymes (blaKPC variants) were determined based on a
study [6]. Amino acid analysis showed that type 2 (KPC-
2) was the predominant variant for species from the
Enterobacteriaceae family, including R. planticola, R.
ornithinolytica and Pantoea spp. In addition, the KPC-2
and KPC-3 variants were predominant in A. baumannii
strains.
Table 5 Frequency of antimicrobial-resistant microorganisms harboring blaKPC
% antibiotic resistance strains with blaKPC genea
Species AMI AMP ASB ATM CFL CEF CTX CFO CAZ CIP POL GEN IMP MER ERT PTZ TIG No. of blaKPC +
Acinetobacter baumannii 23.8 100 100 100 100 100 100 100 100 100 0.0 47.6 100 100 NTb 100 0.0 21
Enterobacter aerogenes 50.0 100 100 100 100 100 100 100 100 33.3 0.0 16.7 83.3 83.3 83.3 83.3 33.3 6
Enterobacter cloacae 20.0 100 100 100 100 100 100 100 100 100 0.0 60.0 100 100 100 100 40.0 6
Escherichia coli 0.0 100 100 100 100 100 100 100 100 100 0.0 100 0.0 0.0 100 100 NTa 1
Klebsiella pneumoniae 13.6 100 100 100 100 100 100 100 100 83.1 11.9 52.5 94.9 88.1 100 100 20.3 60
Pantoea spp. 0.0 100 100 100 100 100 100 100 100 100 0.0 100 100 100 100 100 NTa 1
Raoultella planticola 0.0 100 100 100 100 100 100 100 100 100 100 100 100 50.0 100 100 100 2
Raoultella ornithinolytica 0.0 100 100 100 100 100 100 100 100 100 100 0.0 100 100 100 100 0.0 1
Serratia marcescens 100 100 100 100 100 100 100 100 100 0.0 100 50.0 100 100 100 100 50.0 2
aAMI, amikacin (30 μg); AMP, ampicillin (10 μg); ASB, ampicillin/sulbactam (10/10 μg); ATM, aztreonam (30 μg); CFL, cephalothin (30 μg); CEF, cefepime (30 μg),
CTX, cefotaxime (30 μg); CFO, cefoxitin (30 μg); CAZ, ceftazidime (30 μg), CIP, ciprofloxacin (5 μg); ERT, ertapenem (10 μg); GEN, gentamicin (10 μg); IMP,
imipenem (10 μg); MER, meropenem (10 μg); and PTZ, piperacillin/tazobactam (100/10 μg); POL, Polymixin B (300 U); TIG, Tigecicline (15 μg)
bNT = non-tested
Ribeiro et al. BMC Infectious Diseases  (2016) 16:737 Page 8 of 16
Detection of genes encoding OXA carbapenemase by
Polymerase chain reaction
The primers specific for amplifying of the fragment of
353 bp for blaOXA-51-like gene intrinsic to A. baumannii
species showed that of the 129 isolates 128 harboured
this gene. Only the isolate number 159, identified as A.
ursingii not amplified with this pair of primer. Some rep-
resentative results of amplification are shown in Fig. 1.
DNA fingerprinting analysis by ERIC-PCR
PCR assays with ERIC primers showed heterogeneous
genotypic patterns among the 297 isolates. Reproducible
PCR patterns were observed for all isolates, with frag-
ments that ranged from 70 to 1500 bp. Based on these
polymorphic DNA fingerprinting patterns, ERIC-PCR
analysis revealed clearly distinct DNA profiles from all
the strains analyzed. Visual comparison of the banding
patterns revealed 13 distinct ERIC profiles for 75 K.
pneumoniae isolates, with molecular weights ranging
from 80 to 950 bp. ERIC-PCR analysis for these isolates
showed that 60 (80.0%) had identical profiles, whereas
the other 15 isolates showed heterogeneous profiles.
ERIC-PCR analysis of the 60 blaKPC-positive K. pneu-
moniae strains showed an average of two to five frag-
ments per isolate. Of these, the majority (48, 80.0%)
showed a unique profile, with fragments of 80 and
160 bp (named P01 in Fig. 2). The other 12 isolates
showed heterogeneous profiles, as follows: SL61 [80,
160, 280, 310, 500 bp]; SL62 [80, 160, 280 bp]; SL65 [80,
160, 280, 310 bp]; SL112 [80, 160, 750 bp]; SL121 [80,
100, 160, 200, 310 bp]; SL137 [80, 160, 280, 350,
550 bp]; SL146 [80, 160, 310, 350 bp]; SL154 [80, 160,
280, 310, 450 bp]; SL156 [80, 160, 200, 280, 550 bp];
SL189 and SL265 [160, 310, 350 bp] and SL260 [80, 160,
310 bp], as shown in Fig. 2.
Regarding the ERIC-PCR profiles of the 60 blaKPC-
positive isolates, 20/25 (80.0%) positive isolates from
H10 showed five different patterns: 16 isolates had
identical profiles of 80 and 160 bp (P01, Fig. 2), and four
isolates (SL62, SL112, SL154, SL260) had distinct pro-
files (Fig. 2). For H01, 18/24 (75.0%) positive isolates had
four genetic ERIC-PCR profiles, with 15 of these isolates
showing identical bands of 80 and 160 bp (P01, Fig. 2)
and three isolates (SL137, SL146, SL156) with distinct
genetic profiles (Fig. 2). For H05, 6/6 (100.0%) positive
isolates had three different patterns, with fragments of
80 and 160 bp for four isolates (P01, Fig. 2) and distinct
ERIC-PCR profiles for two isolates (SL121, SL265)
(Fig. 2). For H09, all isolates [5/5 (100.0%)] showed a
single profile of 80 and 160 bp (P01, Fig. 2). For H08,
one isolate [1/1 (100.0%)] had fragments of 80 and
160 bp. For H12, 10/14 (71.4%) ERIC-PCR showed
identical profiles (80 and 160 bp) for seven isolates
(P01, Fig. 2), and SL61, SL65, and SL189 had distinct
patterns (Fig. 2).
ERIC-PCR patterns for the 15 blaKPC-negative K.
pneumoniae isolates showed amplicons of 80 and 160 bp
for 12 isolates, and distinct DNA profiles with fragments
ranging from 80 to 900 bp were amplified in three iso-
lates: SL148 [160, 200, 300, 900 bp]; SL151; and SL153
[80, 160, 280 bp] (Fig. 2).
ERIC-PCR patterns for the 19 Enterobacter cloacae
isolates showed bands that ranged from 80 to 950 bp.
The distinct profiles of 13 isolates that were negative for
the blaKPC gene were as follows: SL29 and SL31 [160,
450 bp]; SL58 and SL312 [80, 160, 310, 450 bp]; SL64
and SL66 [160, 310, 350, 450, 600 bp]; SL155 [80, 160,
450 bp]; SL188 and SL318 [80, 160 bp]; SL206 [160, 310,
350, 450, 480 bp]; SL262 and SL263 [310, 450 bp]; and
SL311 [160, 600 bp] (Fig. 3).
The ERIC-PCR results for six blaKPC-positive Entero-
bacter cloacae isolates showed distinct profiles as fol-
lows: SL59 [80, 160, 280, 310, 350, 700, 950 bp] obtained
from H01; isolate SL261 [310, 450 bp], recovered from
H02; SL271 [310, 450 bp] isolated from H09; SL314
[280, 310, 500, 600, 750 bp], recovered from H11; and
Fig. 1 Agarose gel electrophoresis (2%) of the PCR products with primers specific for the blaOXA-51 gene in isolated evaluated in this study. Lane
1: Molecular pattern: 100 bp marker (Promega Corporation, Madison, USA); Lane 2: PC (positive control)/Acinetobacter baumannii ATCC19606;
Lanes 3–19: Clinical isolates of A. baumannii harboring blaOXA-51 gene (353 bp), and Lane 20: Clinical isolates of A. ursingii
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Fig. 2 Dendrogram showing the genetic relatedness of 75 Klebsiella pneumoniae isolates. Cluster analysis of enterobacterial repetitive intergenic
consensus PCR (ERIC-PCR) fingerprinting patterns using the DICE similarity coefficient and the UPGMA cluster method. The scale indicates the
percentage of genetic similarity
Fig. 3 Dendrogram showing the genetic relatedness of 45 other isolates from the Enterobacteriaceae family. Cluster analysis of enterobacterial
repetitive intergenic consensus PCR (ERIC-PCR) fingerprinting patterns using the DICE similarity coefficient and the UPGMA cluster method. The
scale indicates the percentage of genetic similarity
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SL67 and SL75 [160, 280, 310, 450, 550 bp], which were
recovered from H12 (Fig. 3).
Among isolates positive and negative for the blaKPC
gene, ERIC-PCR amplicons ranged between 80 and
900 bp for nine isolates identified as Enterobacter aero-
genes. Two different profiles were observed for three
strains negative for this gene. For the SL147 and SL193
isolates, bands of 80 and 160 bp were observed, and for
SL80, the profile was 100, 280, 310, 450, 550, and
900 bp. The presence of blaKPC was detected in six other
isolates that showed heterogeneous patterns as follows:
SL63 [160, 280, 450, 500 bp], recovered from H07; SL78
[160, 280, 310, 400, 500 bp], isolated from H09; isolates
SL204 and SL205 [310, 450 bp] and SL211 [160,
280 bp], obtained from H05; and SL323 [160, 310,
500 bp], isolated from H12 (Fig. 3).
For five isolates identified as Serratia marcescens,
ERIC-PCR fragments ranged between 80 and 310 bp.
Isolates SL55, SL56 and SL209, which were negative for
the blaKPC gene, exhibited a single profile of 80 and
160 bp. The isolates SL04 and SL111, positive for
blaKPC, showed bands of 80, 160, and 310 bp. These
strains were isolated from patients treated at H05, a
public hospital emergency room (Fig. 3).
The ERIC-PCR profiles for the three isolates identified
as Pantoea spp. were 80, 200, 280, 400, and 650 bp for
SL57 and 80, 160, 280, 350, 650, and 1200 bp for SL71.
The strain SL207, which was positive for the blaKPC gene
and obtained from H15, showed a single fragment of
350 bp (Fig. 3).
Two strains identified as E. coli showed distinct ERIC-
PCR profiles; blaKPC-positive SL141 was recovered from
a patient at the H09 hospital, and showed fragments of
80, 160, 280, 350, and 550 bp, and the blaKPC-negative
SL322 isolate had fragments of 160 and 250 bp (Fig. 3).
ERIC-PCR patterns of 80 and 160 bp were observed
for three different isolates as follows: for those identified
as Raoultella planticola, which included SL36 obtained
from H10 and SL196 from H01, and for SL110, which
was identified as Raoultella ornithinolytica and recov-
ered from H10. The blaKPC gene was detected in all
these isolates.
For three Proteus mirabilis isolates, SL26, SL310 and
SL313, a unique profile of 160 bp was observed. For the
Aeromonas salmonicida strain SL210, fragments of 80
and 160 bp were found. All these isolates were negative
for the blaKPC gene (Fig. 3).
The distribution of different blaKPC-positive species in
hospitals was as follows: for H01, K. pneumoniae, En-
terobacter cloacae and Raoultella planticola; for H02,
only Enterobacter cloacae; for H05, K. pneumoniae, En-
terobacter aerogenes and Serratia marcescens; for H07,
only Enterobacter aerogenes; for H08, only K. pneumo-
niae; for H09, K. pneumoniae, Enterobacter cloacae,
Enterobacter aerogenes and E. coli; for H10, K. pneumo-
niae, Raoultella planticola and Raoultella ornithinoly-
tica; for H11, only Enterobacter cloacae; for H12, K.
pneumoniae and Enterobacter cloacae; and for H15, only
Pantoea spp. It is important to note that H09, a public
emergency room, had the highest number of different
bacterial species carrying the blaKPC gene.
In summary, the results of ERIC-PCR for 120 isolates
belonging to the Enterobacteriaceae family showed that
79 (65.8%) bacterial strains carried the blaKPC gene.
Among these isolates, 26 (33.0%) clones were genetically
distinct and were circulating in most [10/16 (62.6%)] of
the hospitals surveyed.
Among the 297 bacterial isolates, 177 (59.6%) were
non-fermenting Gram-negative bacilli from the genera
Acinetobacter (n = 129) and Pseudomonas (n = 48). The
profiles produced by ERIC-PCR with DNA of these mi-
croorganisms were quite heterogeneous, with fragments
ranging from 70 to 1500 bp. Of the 177 isolates, 128
(72.3%) were identified as A. baumannii and one A.
ursingii (SL159). Of the 128 isolates of A. baumannii,
the majority (107, 83.5%) was negative for the blaKPC
gene, and this gene was found in only 21 (16.5%) strains.
The major genotyping profile found by ERIC-PCR for
KPC-negative A. baumannii isolates was 100, 150, and
300 bp in 56 isolates (52.3%), which was named PA01
(Fig. 4), followed by 24 isolates with profiles of 100 and
150 bp (PA02 in Fig. 4). In addition, five isolates—SL90,
SL91, SL97, SL124, and SL168—showed fragments of
100, 150, 300, 500, and 600 bp (PA03, Fig. 4); seven iso-
lates—SL09, SL11, SL17, SL43, SL50, SL304, and
SL306—had profiles with 100 and 350 bp (PA04, Fig. 4);
and six isolates (SL84, SL87, SL93, SL99, SL101, SL135)
had profiles of 100, 350, and 900 bp (PA05, Fig. 4). Het-
erogeneous patterns were observed for nine isolates,
with fragments ranging from 100 to 1500 bp. Among
these isolates, the profiles were as follows: SL95 and
SL96 (150, 500, 600 bp); SL242 and SL243 (150, 300,
500, 900 bp); SL01 (150, 300, 480, 600, 900 bp); SL02
(150, 300, 350, 450, 900 bp); SL92 and SL305 (150,
300 bp); and SL228 (100, 150, 350, 500, 900, 1000,
1500 bp). The isolate SL159, identified as A. ursingii,
was negative for the blaKPC gene and showed the follow-
ing profile: 150, 250, and 300 bp (Fig. 4).
ERIC-PCR analysis revealed that the 21 blaKPC-posi-
tive A. baumannii isolates had the following profiles:
four isolates (SL231, SL232, SL233, SL235) with 100,
150, 350, 900, 1000, and 1500 bp, (profile PA06, Fig. 4);
seven isolates (SL77, SL178, SL226, SL227, SL236,
SL244, SL298) with 100, 150, 200, and 350 bp (PA07,
Fig. 4); five isolates (SL100, SL107, SL125, SL126 and
SL134) with 100, 150, and 350 bp (PA08, Fig. 4) and het-
erogeneous banding profiles for isolates SL106 [100, 150,
500, 900 bp]; SL163 [100, 150, 200, 250, 350, 750 bp];
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SL230 [150, 350, 750, 1500 bp]; SL246 [100, 350, 500,
600, 750 bp]; and SL250 [100, 150, 200, 300, 500,
900 bp], as shown in Fig. 4.
Regarding the presence of blaKPC in bacterial isolates,
PCR assays revealed that of the 37 strains of A. bauman-
nii obtained from H01, this gene was detected in seven
(19%) of the clinical isolates (SL77, SL125, SL178,
SL226, SL232, SL236, SL298), showing that three differ-
ent bacterial clones containing the blaKPC gene were cir-
culating in H01 (Fig. 4, P06, PA07, PA08). In H02, [5/15
(33.3%)] five isolates—SL233, SL235, SL227, SL126 and
SL106—had ERIC-PCR patterns very heterogeneous
(Fig. 4, P06, PA07, PA08), showing that four different
clones were circulating in this hospital. For H03, [1/6
(16.6%)] isolate SL246 showed a single profile. In H10,
[8/44 (18.1%)] eight isolates were grouped into distinct
profiles, including SL231 (PA06, Fig. 4); SL244 (PA07,
Fig. 4); SL100, SL07 and SL134 (PA08, Fig. 4); and
SL163, SL230, and SL250, which had heterogeneous pro-
files (Fig. 4), showing that six clones were circulating in
this hospital.
ERIC-PCR profiles for Pseudomonas spp. isolates
showed different size fragments for the three different
species. For P. fluorescens isolate SL184, the observed
bands were 150, 200, and 250 bp; the five isolates
(SL138, SL139, SL142, SL143 and SL225) identified as
P. putida had a single profile of 100 and 150 bp. For the
42 P. aeruginosa isolates, the majority (26, 62%) showed
the same profile, with fragments of 100, 150, and 300 bp
(PA, Fig. 5); seven isolates (SL254, SL255, SL284, SL285,
SL286, SL289, SL290) had bands of 150, 280, 320, and
600 bp (PB, Fig. 5); and for five isolates (SL256, SL257,
SL258, SL259, SL293), the fragments were 100, 200,320,
and 400 bp (PC, Fig. 5). Furthermore, four isolates
showed heterogeneous profiles: SL40 [150, 250, 280,
320 bp]; SL94 [100, 200, 250, 320, 400 bp]; SL116 [150,
200, 280, 320, 1200 bp], and SL224 [100, 150, 300,
1000 bp]. It is important to note that the blaKPC gene
was not detected in bacilli belonging to the genus
Pseudomonas.
Discussion
This study showed the spread of multi-drug-resistant
(MDR) bacterial strains isolated from clinical samples
from patients in different healthcare facilities (public and
private hospitals in northeastern Brazil) who showed re-
sistance or decreased carbapenem antimicrobial suscepti-
bility to imipenem, meropenem or ertapenem. The
increasing prevalence of the clinical MDR-KPC phenotype
has been associated with higher mortality rates, thereby
posing a considerable threat to public health [21].
Our analysis indicated that A. baumannii, K. pneumo-
niae and P. aeruginosa species were the most frequently
observed in clinical samples, with carbapenem resistance
Fig. 4 Dendrogram showing the genetic relatedness of 129 Acinetobacter spp. isolates. Cluster analysis of enterobacterial repetitive intergenic
consensus PCR (ERIC-PCR) fingerprinting patterns using the DICE similarity coefficient and the UPGMA cluster method. The scale indicates the
percentage of genetic similarity
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frequencies of 100, 84 and 100%, respectively. The high
percentages of bacterial resistance to carbapenems and
the cross-resistance observed to various antimicrobials
are of concern in clinical medicine, especially in intensive
care units [22]. It is possible that the genes encoding car-
bapenemases are located on genetic elements, such as
integrons and transposons, in association with conjugative
plasmids typically carrying genes for resistance to other
antimicrobials [23]. Recently, the blaKPC-3, blaVIM-1,
blaSHV-12, blaOXA-9 and blaCMY-2 genes were detected in a
unique clinical multidrug-resistant E. coli isolate (clone
ST448) carrying a Tn4401 transposon associated with an
IncFII plasmid [24]. Moreover, blaKPC variant genes are
typically located in Tn4401 transposable elements and
their isoforms, supporting their dispersion [25].
We found that several isolates of the Enterobacteria-
ceae family were resistant to most of the antimicrobials
tested, except for Polymixin and amikacin. We observed
that 10.7% of the K. pneumoniae strains were resistant
to Polymixin B, with an MIC of 64 μg/ml. The other
species were sensitive to Polymixin B. This antimicrobial
drug is a good treatment option for A. baumannii, E.
aerogenes, E. cloacae and E. coli, followed by amikacin, even
in the presence of varying percentages of resistance [26].
This study has thus far been categorical in stating that
the antimicrobial agent amikacin is a therapeutic option
for the treatment of infections. Nevertheless, it has
emerged, alone or in combination, as a major drug of
interest for treating isolates that possess intrinsic resist-
ance to Polymixin [26]. The combination of Polymixin
with tigecycline has recently been described as a suitable
option for the treatment of infections with MDR Gram-
negative pathogens extended spectrum beta lactamase
(ESBL- and carbapenemase-producing strains) [15].
However, increased expression of the efflux system in A.
baumannii isolates has been correlated with a low level
of susceptibility to tigecycline [27].
Molecular approaches aimed at detecting strains harbor-
ing carbapenemase genes are highly sensitive and efficient
for confirmation of cases [28, 29]. Conversely, there are
no methodologies to routinely conduct clinical and la-
boratory diagnoses [30]. In this respect, the presence of
the blaKPC gene must be confirmed by molecular biology
techniques to define the production of KPCs [28]. The
production of KPCs determined by the phenotypic modi-
fied Hodge test (MHT) showed a strong association with
the presence of the blaKPC gene by PCR (p < 0.0001).
However, analyses showed that MHT positivity does not
confirm the presence of KPCs, only the involvement of
some KPCs that may or may not indicate a resistant
phenotype. It is important to note that false positive re-
sults can occur when the MHT is used to detect carbape-
nemase in ESBL-producing isolates [7]. However, only one
isolate was blaKPC gene-positive and MHT-negative. Simi-
lar to our findings, patterns of antimicrobial resistance
and prevalence of the blaKPC gene were determined in
Fig. 5 Dendrogram showing the genetic relatedness of Pseudomonas spp. isolates. Cluster analysis of enterobacterial repetitive intergenic
consensus PCR (ERIC-PCR) fingerprinting patterns using the DICE similarity coefficient and the UPGMA cluster method. The scale indicates the
percentage of genetic similarity
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Enterobacteriaceae species isolated from a hospital in
India. Among 46 strains resistant to carbapenem antimi-
crobials, 38 (82.6%) tested positive by MHT, but the
blaKPC gene was detected in only 31 (67.4%) [31].
The emergence of antibiotic-resistant organisms is a
major public health concern, particularly in hospitals
and other health care settings, and represents a serious
challenge for surveillance systems [32, 33]. Previous
studies have shown the spread of KPC-type 2 and KPC-
type 3 strains and have also identified new variants, such
as blaKPC-15 [7, 34, 35]. Mortality rates of 18–72% have
been reported in patients infected with bacteria carrying
the blaKPC gene in recent years [33, 36, 37], including
those treated with combined therapy (tigecycline-gentami-
cin or tigecycline-colistin) or monotherapy using colistin
or tigecycline for Enterobacteriaceae infections [15].
In Brazil, KPC-2 has been endemic since 2006 [10],
and our surveillance systems have failed to detect KPC,
its variants and their incidence rates. Moreover, we do
not know the true prevalence of these carbapenemases
and their impacts on hospital mortality rates. However,
the few existing studies have suggested that the mortality
rate associated with KPC infection in intensive care
units in Brazil can reach 18% [38]. Recently, the first de-
scription of the K. pneumoniae clone ST258 associated
with an outbreak in Ribeirão Preto city, Brazil was re-
ported. This clone carried the transposon Tn4401a,
which likely contributed to its spread [39].
Previous studies have indicated that the prevalence of
the blaKPC gene in A. baumannii is variable and not al-
ways indicative of β-lactam antimicrobial resistance with
this type of KPC [40]. Other reports have indicated that
high levels of resistance to carbapenems are strongly re-
lated to the presence of the blaOXA-23 and blaOXA-24
genes [41]. Furthermore, this study showed that 21
(16.4%) Acinetobacter strains harbored the blaKPC gene
among the 128 bacterial strains evaluated. A more re-
cent study found that despite the apparent spread of the
blaKPC gene in A. baumannii isolates causing nosoco-
mial outbreaks, additional types of carbapenemases are
involved in the activity of this bacterial species and are
associated (or not) with other non-enzymatic mecha-
nisms, including changes in outer membrane protein
(OMPs) efflux pumps and penicillin-binding proteins
(PBP) [42].
Moreover, it is important to note that all isolates previ-
ously identified by biochemical tests as Acinetobacter
spp were confirmed by PCR for identification at the
species-level. Among the various genotypic methods
used to identify isolates of the genus Acinetobacter, the
PCR of the blaoxa51 gene has been proposed as a method
to identify A. baumannii [19].
In Enterobacteriaceae carrying the blaKPC gene, a high
level of sensitivity to Polymixin was observed; however,
it is worrisome that some strains showing resistance to
this antimicrobial agent have emerged, including patho-
gens with intrinsic resistance. Previous reports have de-
scribed the presence of KPC-3-producing K. pneumoniae
that are resistant to colistin (Polymixin E) in hospitals in
Sicily, Italy [21, 43]. In addition, high percentages (83.1%)
of ciprofloxacin resistance have been observed in K. pneu-
moniae strains carrying the blaKPC gene, indicating that
few antimicrobial options may be available because these
microorganisms accumulate different mechanisms of
resistance.
Molecular genotyping using ERIC-PCR fingerprinting
showed heterogeneous profiles that could differentiate
bacterial species that contained these repetitive elements.
ERIC-PCR patterns showed 26 distinct clones for eight
bacterial species of the family Enterobacteriaceae and
eight different clones for strains of Acinetobacter bauman-
nii that were resistant to carbapenems and that were
circulating in 11/16 (68.7%) of the hospitals surveyed.
The high discriminatory ability of the ERIC-PCR
technique shown here is relevant and similar to
others studies [44–51].
Conclusions
The results of this molecular epidemiology survey indi-
cate that bacteria of the Enterobacteriaceae family are
still common carriers of blaKPC gene variant 2 (KPC-2).
However, the large number of Acinetobacter baumannii
isolates carrying KPC-2 and KPC-3 variants is worri-
some because this microorganism is an important op-
portunistic MDR pathogen that is frequently found to
cause infections in inpatients and individuals throughout
the community. Here, we have demonstrated the im-
portance of monitoring hospitalized patients for the fur-
ther emergence of carbapenem resistance in these
bacteria as well as other Gram-negative pathogens. The
high rates of clones carrying the blaKPC gene suggest the
need to improve the quality of health care to reduce the
incidence of infections.
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